We seek licensing-in cooperation with external
partners to access innovative technology
platforms, drugs, or therapies.
By collaborating with industry-leading research
institutions, biotechnology companies, and
academia, we hope to obtain new therapies
and technology platforms that will generate
synergies with our pipeline and further expand
our product lines and R&D areas.